HelpAcademyLoginJoin us as a Member

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Sign in to save CHARLES RIVER LABORATORIES INTERNATIONAL, INC. to a watchlist Sign in to set an alert for CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tickers
CRL
Headquarters
Not recorded
SEC CIK
0001100682
Website
Not recorded

Closing prices

Latest close, 376.10

Closing prices for CRL249 stored closes for CRL from 3 Nov 2025 to 29 Oct 2026. Lowest 149.93 on 18 May 2026, highest 376.10 on 29 Oct 2026, latest 376.10 on 29 Oct 2026.Close100.00200.00300.00400.003 Nov 20251 May 202629 Oct 2026
249 stored closes, oldest first. End of day, not intraday.

Source: Massive Closing prices as of End-of-day prices, not live

Massive Basic, non-business use; display licence needed before launch (D-1). Marketstack is kept as the backup source.

Not investment advice. End-of-day closing prices, not live quotes.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

No Drugs@FDA application has a sponsor name that matches this company.

Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

SEC filings

SEC filings from CHARLES RIVER LABORATORIES INTERNATIONAL, INC., newest first
FormFiledWhat it coversDocument
4 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 26 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000153 (opens in a new tab)
4Event 21 Oct 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 23 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000151 (opens in a new tab)
4Event 5 Oct 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 7 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001952784-26-000003 (opens in a new tab)
4Event 30 Sep 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 2 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000144 (opens in a new tab)
8-K Current report (8-K)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 24 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000142 (opens in a new tab)
4Event 25 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 27 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000140 (opens in a new tab)
4Event 19 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 20 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000138 (opens in a new tab)
4Event 19 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 20 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000136 (opens in a new tab)
4Event 18 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 20 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000134 (opens in a new tab)
4Event 11 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 13 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001100682-26-000132 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

All rows for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. on Insider Trades

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
17 transactions, 90,990 shares, $25,731,412.79
Other all other codes
13 transactions: grants, exercises, tax withholding, gifts and similar

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.